KE3283A - A phenylakylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it - Google Patents

A phenylakylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it

Info

Publication number
KE3283A
KE3283A KE3283A KE328383A KE3283A KE 3283 A KE3283 A KE 3283A KE 3283 A KE3283 A KE 3283A KE 328383 A KE328383 A KE 328383A KE 3283 A KE3283 A KE 3283A
Authority
KE
Kenya
Prior art keywords
acid addition
optical isomer
labetalol
protected
phenylakylaminoethylsalicylamide
Prior art date
Application number
KE3283A
Other languages
English (en)
Inventor
Elijah Herman Gold
Wei Chang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of KE3283A publication Critical patent/KE3283A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
KE3283A 1978-09-20 1983-04-25 A phenylakylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it KE3283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94451678A 1978-09-20 1978-09-20

Publications (1)

Publication Number Publication Date
KE3283A true KE3283A (en) 1983-05-13

Family

ID=25481553

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3283A KE3283A (en) 1978-09-20 1983-04-25 A phenylakylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it

Country Status (27)

Country Link
EP (1) EP0009702B1 (de)
JP (3) JPS5555147A (de)
KR (2) KR830000904A (de)
AT (1) ATE351T1 (de)
AU (1) AU528626B2 (de)
CA (1) CA1151211A (de)
CY (1) CY1175A (de)
DD (1) DD150457A5 (de)
DE (1) DE2961263D1 (de)
DK (1) DK387579A (de)
FI (1) FI792884A (de)
GR (1) GR73179B (de)
HK (1) HK13383A (de)
HU (1) HU185523B (de)
IE (1) IE49301B1 (de)
IL (1) IL58258A (de)
KE (1) KE3283A (de)
MY (1) MY8500042A (de)
NO (1) NO149660C (de)
NZ (1) NZ191589A (de)
OA (1) OA06339A (de)
PH (1) PH16794A (de)
PL (1) PL129114B1 (de)
PT (1) PT70191A (de)
SG (1) SG283G (de)
YU (1) YU227379A (de)
ZA (1) ZA794872B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide
IT1194406B (it) * 1983-09-27 1988-09-22 Scharper S P A Procedimento per la preparazione di 2-idrossi-5-01-idrossi-2-((4-fenil-2-butil)ammino) etil benzammide
HU190867B (en) * 1984-01-20 1986-11-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing 2-hydroxy-5-/1-hydroxy-2-/1-methyl-3-phenyl-propyl/-amino/ethyl/-benzamide and pharmaceutically acceptable salts thereof
US4788183A (en) * 1987-11-30 1988-11-29 Schering Corporation Method for treatment of dyslipidemia in humans
US4879233A (en) * 1989-02-10 1989-11-07 Schering Corporation Novel Aspergillus niveus microorganism used for the chiral reduction of carbonyl groups
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
DK1281702T3 (da) * 1991-08-23 2006-04-18 Nps Pharma Inc Calciumreceptoraktive molekyler
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
CA2202879C (en) 1994-10-21 2005-08-30 Bradford C. Van Wagenen Calcium receptor-active compounds
ES2201300T3 (es) * 1996-05-01 2004-03-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
IT1313583B1 (it) 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
PT1961735E (pt) * 2007-02-22 2009-12-21 Indena Spa Processo para a preparação de sal de acetato de éster metílico de (2r,3s)-3-fenilisoserina
WO2012021629A2 (en) 2010-08-11 2012-02-16 Philadelphia Health & Education Corporation Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1266058A (de) * 1969-07-08 1972-03-08
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
NL7603965A (nl) * 1975-04-17 1976-10-19 Scherico Ltd Diastereoisomeren van fenylaminoethanolderi- vaten met farmacologische activiteit en werk- wijzen om deze te bereiden.

Also Published As

Publication number Publication date
FI792884A (fi) 1980-03-21
KR840005307A (ko) 1984-11-05
JPH0210128B2 (de) 1990-03-06
IE791770L (en) 1980-03-20
ATE351T1 (de) 1981-11-15
EP0009702A1 (de) 1980-04-16
DE2961263D1 (en) 1982-01-14
HK13383A (en) 1983-04-29
IL58258A0 (en) 1979-12-30
PL129114B1 (en) 1984-03-31
SG283G (en) 1983-09-16
OA06339A (fr) 1981-06-30
AU528626B2 (en) 1983-05-05
IE49301B1 (en) 1985-09-18
HU185523B (en) 1985-02-28
AU5088179A (en) 1980-03-27
NO149660B (no) 1984-02-20
PT70191A (en) 1979-10-01
JPS5555147A (en) 1980-04-22
KR890001998B1 (ko) 1989-06-07
PH16794A (en) 1984-02-28
DD150457A5 (de) 1981-09-02
YU227379A (en) 1983-06-30
NZ191589A (en) 1984-03-30
IL58258A (en) 1984-01-31
JPH02167253A (ja) 1990-06-27
NO792993L (no) 1980-03-21
GR73179B (de) 1984-02-14
CY1175A (en) 1983-06-10
ZA794872B (en) 1980-11-26
DK387579A (da) 1980-03-21
EP0009702B1 (de) 1981-11-04
KR830000904A (ko) 1983-04-28
CA1151211A (en) 1983-08-02
JPS59108749A (ja) 1984-06-23
NO149660C (no) 1984-05-30
MY8500042A (en) 1985-12-31
PL218408A1 (de) 1980-09-08

Similar Documents

Publication Publication Date Title
DE2961263D1 (en) A phenylalkylaminoethylsalicylamide, its preparation and pharmaceutical compositions containing it
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
CA2092794A1 (fr) Naphtylalkylamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES8506730A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
AU624031B2 (en) Compositions and their use in lowering intraocular pressure
PT90022A (pt) Processo para a preparacao de derivados cefem e dos intermediarios correspondentes
MY111055A (en) Pharmaceutical composition and process for the preparation thereof
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
IL124296A0 (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
WO1990003172A3 (en) Bile acids for treatment of viral infections
ES524375A0 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
IL69448A (en) Process for combating phytopathogenic fungi with azolylphenoxy-tetrahydrofuran-2-ylidene methane derivatives
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
JPS5540601A (en) New 3-(3,4-dihydroxyphenyl)serine derivative
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them